
Multiple Sclerosis
What Have We Learned From Magnetic Resonance Imaging Studies?
Samia J. Khoury, MD;
Howard L. Weiner, MD
Arch Intern Med. 1998;158:565-573.
We review studies that have examined the relationship between magnetic resonance imaging findings and clinical disability, postmortem observations, and cognitive dysfunction in patients with multiple sclerosis. We also review the use of magnetic resonance imaging findings as an outcome measure in clinical trials assessing the efficacy of new therapeutic agents for the treatment of multiple sclerosis. More advanced applications of magnetic resonance imaging and their use in multiple sclerosis is addressed later in the article.
From the Center for Neurologic Diseases, Brigham and Women's Hospital, Boston, Mass.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Randomized study of antibodies to IFN-g and TNF-a in secondary progressive multiple sclerosis
Skurkovich et al.
Mult Scler 2001;7:277-284.
ABSTRACT
Changes in serum levels of ICAM and TNF-R correlate with disease activity in multiple sclerosis
Khoury et al.
Neurology 1999;53:758-758.
ABSTRACT
| FULL TEXT
|